Edwards Lifesciences Navigates Slower TAVR Growth With Adoption of TMTT Valves
Overall, Edwards enjoys a great deal of financial flexibility that would allow for more substantial acquisitions, if those opportunities were to arise. Edwards Lifesciences has come to dominate ...
Investor's Business Daily on MSN9h
Edwards Makes A Bullish Move As Heart-Valve Replacements Top $1 Billion
Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.